Psoriatic Arthritis (PsA) Treatment Market Report

Global Psoriatic Arthritis (PsA) Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：236
  • REPORT CODE：GMM847889
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Psoriatic Arthritis (PsA) Treatment market report explains the definition, types, applications, major countries, and major players of the Psoriatic Arthritis (PsA) Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Amgen Inc

    • Celgene Corporation

    • AstraZeneca plc

    • Bausch Health Companies Inc

    • Novartis International AG

    • Johnson & Johnson Services Inc

    • AbbVie Inc

    By Type:

    • Nonsteriodal Anti-inflammatory Drugs

    • Disease Modifying Antirheumatic Drugs

    • Biologics

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Psoriatic Arthritis (PsA) Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Psoriatic Arthritis (PsA) Treatment Outlook to 2028- Original Forecasts

    • 2.2 Psoriatic Arthritis (PsA) Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Psoriatic Arthritis (PsA) Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Psoriatic Arthritis (PsA) Treatment Market- Recent Developments

    • 6.1 Psoriatic Arthritis (PsA) Treatment Market News and Developments

    • 6.2 Psoriatic Arthritis (PsA) Treatment Market Deals Landscape

    7 Psoriatic Arthritis (PsA) Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Psoriatic Arthritis (PsA) Treatment Key Raw Materials

    • 7.2 Psoriatic Arthritis (PsA) Treatment Price Trend of Key Raw Materials

    • 7.3 Psoriatic Arthritis (PsA) Treatment Key Suppliers of Raw Materials

    • 7.4 Psoriatic Arthritis (PsA) Treatment Market Concentration Rate of Raw Materials

    • 7.5 Psoriatic Arthritis (PsA) Treatment Cost Structure Analysis

      • 7.5.1 Psoriatic Arthritis (PsA) Treatment Raw Materials Analysis

      • 7.5.2 Psoriatic Arthritis (PsA) Treatment Labor Cost Analysis

      • 7.5.3 Psoriatic Arthritis (PsA) Treatment Manufacturing Expenses Analysis

    8 Global Psoriatic Arthritis (PsA) Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Psoriatic Arthritis (PsA) Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Psoriatic Arthritis (PsA) Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Psoriatic Arthritis (PsA) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Nonsteriodal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Disease Modifying Antirheumatic Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Biologics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Psoriatic Arthritis (PsA) Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.2.2 Canada Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.2 UK Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.3 Spain Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.5 France Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.6 Italy Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.8 Finland Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.9 Norway Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.11 Poland Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.12 Russia Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.2 Japan Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.3 India Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.3 Chile Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.6 Peru Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.6.3 Oman Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    11 Global Psoriatic Arthritis (PsA) Treatment Competitive Analysis

    • 11.1 Amgen Inc

      • 11.1.1 Amgen Inc Company Details

      • 11.1.2 Amgen Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Amgen Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.1.4 Amgen Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Celgene Corporation

      • 11.2.1 Celgene Corporation Company Details

      • 11.2.2 Celgene Corporation Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Celgene Corporation Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.2.4 Celgene Corporation Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 AstraZeneca plc

      • 11.3.1 AstraZeneca plc Company Details

      • 11.3.2 AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.3.4 AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bausch Health Companies Inc

      • 11.4.1 Bausch Health Companies Inc Company Details

      • 11.4.2 Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.4.4 Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis International AG

      • 11.5.1 Novartis International AG Company Details

      • 11.5.2 Novartis International AG Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis International AG Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.5.4 Novartis International AG Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Johnson & Johnson Services Inc

      • 11.6.1 Johnson & Johnson Services Inc Company Details

      • 11.6.2 Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.6.4 Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 AbbVie Inc

      • 11.7.1 AbbVie Inc Company Details

      • 11.7.2 AbbVie Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 AbbVie Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

      • 11.7.4 AbbVie Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Psoriatic Arthritis (PsA) Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Nonsteriodal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Disease Modifying Antirheumatic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Psoriatic Arthritis (PsA) Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Psoriatic Arthritis (PsA) Treatment

    • Figure of Psoriatic Arthritis (PsA) Treatment Picture

    • Table Global Psoriatic Arthritis (PsA) Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Psoriatic Arthritis (PsA) Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Nonsteriodal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Disease Modifying Antirheumatic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Table North America Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure United States Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure Germany Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure Brazil Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure Australia Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Amgen Inc Company Details

    • Table Amgen Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table Amgen Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Table Celgene Corporation Company Details

    • Table Celgene Corporation Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table Celgene Corporation Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Table AstraZeneca plc Company Details

    • Table AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Table Bausch Health Companies Inc Company Details

    • Table Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Table Novartis International AG Company Details

    • Table Novartis International AG Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table Novartis International AG Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Table Johnson & Johnson Services Inc Company Details

    • Table Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Table AbbVie Inc Company Details

    • Table AbbVie Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Psoriatic Arthritis (PsA) Treatment Main Business and Markets Served

    • Table AbbVie Inc Psoriatic Arthritis (PsA) Treatment Product Portfolio

    • Figure Global Nonsteriodal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disease Modifying Antirheumatic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US